Immucell Corp (ICCC) Reports Q4 Loss of $0.15

Immucell Corp (NASDAQ: ICCC) reported Q4 EPS of ($0.15). Revenue for the quarter came in at $5.09 million.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results